Site Map
- Home - Proteonomix, Inc.
- Who We Are - About Proteonomix
- What We Do
- Product Development
- MD And Healthcare Practitioners
- Investor Information
- Media Inquiries
- News & Events
- Aug 17, 2010 - Proteonomix Announces Joint Venture in the United Arab Emirates
- Aug 6, 2010 - Proteonomix Announces New Subsidiary XGen Medical LLC
- Aug 2, 2010 - Proteonomix Provides Update on International Joint Venture Strategy
- June 16, 2010 - Proteonomix Now available for trading on the OTC Bulletin Board with the symbol: PROT
- June 1, 2010 - Proteonomix, Inc. (PROT) Concentrates Its R & D Efforts on the Development of Its Subsidiary StromalCel, Inc. in Order to Enhance Its Portfolio of Intellectual Properties and Global Partnerships
- May 28, 2010 - Proteoderm, Inc. a Wholly Owned Subsidiary of Proteonomix, Inc. (PROT) Announces New Product Development - Proteoderm PS
- May 24, 2010 - Proteonomix, Inc. Announces Its Subsidiary, Proteoderm, Inc. Commences Operation of Retail Web Site -- Accepting Pre-Orders, for Revolutionary Cosmetic Product on Monday
- May 4, 2010 - Proteonomix Announces Licensed Stromal Cell Technology for Potential Therapeutic Use in the Regrowth of Damaged Cardiac Cells After a Heart Attack
- April 22, 2010 - Proteonomix Announces It Has Cleared Comments in Its Registration Statement Filed With the Securities and Exchange Commission and Is Applying for a Listing on the OTCBB
- March 10, 2010 - Proteonomix, Inc. Announces the Formation of PRTMI RD S.R.L. as a PRTMI Subsidiary
- February 25, 2010 - Proteonomix Announces the Appointment of Ashoke Agarwal, M.D. as Chief Scientific Officer of Its Subsidiary, StromalCel, Inc.
- February 18, 2010 - Proteonomix Announces the Formation of StromaCel, Inc.
- February 12, 2010 - Proteonomix, Inc. (PROT) Announces the Formation of Proteonomix Regenerative Translational Medicine Institute, Inc.
- January 25, 2010 - Proteonomix Responds to Recent Internet Articles Relating to its Subsidiary, Proteoderm, Inc.
- December 30, 2009 - Proteonomix, Inc. Announces Change in Board of Directors / Principal Officers
- Careers
- Partners
- Contact
- Cardiac Therapy
- Diabetes
- Under Development
|
